跳至主要内容
临床试验/JPRN-jRCTs071200005
JPRN-jRCTs071200005已完成2 期

Validation of safety and efficacy for Axillary Reverse Mapping (ARM) using indocyanine green to prevent lymph edema due to breast cancer surgery

agayasu Takeshi0 个研究点目标入组 15 人开始时间: 2020年4月20日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
15

研究概览

简要总结

ARM with indocyanine green could be safely performed and lymphatic vessels could be identified in all cases. If the main lymphatic vessels and ARM lymph nodes can be preserved, lymphedema development may be reduced.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1. age: over 20 year-old at an informed consent
  • 2. gender: unmentioned
  • 3. patients diagnosed as positive in axillary lymph nodes before surgery and positive in sentinel lymph nodes during surgery
  • 4. Neoadjuvant chemotherapy: unmentioned
  • 5. patients with a witten informed consent and good comprehension after enough explanation about this study

排除标准

  • 1. patients who had developed lymph edema before surgery
  • 2. patients with severe liver dysfunction
  • 3. patients with past history of allergy for the indocyanine green and iodine
  • 4. pregnent patients
  • 5. patients who undergo bilateral axillary lymph node dissection
  • 6. other patients who were judged as inappropriate by the chief physician for this study

研究者

发起方
agayasu Takeshi

相似试验